We are live on
!
Find out more
BC
Brookfield Corp Portfolio holdings
AUM
$77B
1-Year Est. Return
10.33%
This Fund
S&P 500
This Quarter
Est. Return
+1.7%
1 Year Est. Return
-10.33%
3 Year Est. Return
+16.96%
5 Year Est. Return
+12.9%
10 Year Est. Return
+99.88%
AUM
$25.3B
AUM Growth
-$717M
(-2.8%)
Cap. Flow
-$298M
Cap. Flow
% of AUM
-1.18%
Top 10 Holdings %
Top 10 Hldgs %
66.75%
Holding
801
New
140
Increased
161
Reduced
253
Closed
224
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBUC
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
|
+$945M |
| 2 |
Brookfield Renewable
BEP
|
+$158M |
| 3 |
Exelon
EXC
|
+$154M |
| 4 |
Enterprise Products Partners
EPD
|
+$105M |
| 5 |
CMS Energy
CMS
|
+$70.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eversource Energy
ES
|
+$155M |
| 2 |
FirstEnergy
FE
|
+$148M |
| 3 |
American Electric Power
AEP
|
+$135M |
| 4 |
PG&E
PCG
|
+$112M |
| 5 |
CenterPoint Energy
CNP
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.22% |
| 2 | Energy | 24.66% |
| 3 | Utilities | 23.2% |
| 4 | Industrials | 9.27% |
| 5 | Real Estate | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Establishment Labs
ESTA
$2.11B
| $1.25M | ﹤0.01% |
+18,163
| New | +$1.25M |
|
452
Maravai LifeSciences
MRVI
$1.14B
| $1.22M | ﹤0.01% |
97,854
-61,191
| -38% | -$826K |
|
453
Chevron
CVX
$396B
| $1.21M | ﹤0.01% |
7,670
-5,061
| -40% | -$811K |
|
454
Bristol-Myers Squibb
BMY
$136B
| $1.19M | ﹤0.01% |
18,603
+8,987
| +93% | +$603K |
|
455
DTE Energy
DTE
$28.3B
| $1.17M | ﹤0.01% |
+10,591
| New | +$1.18M |
|
456
Oscar Health
OSCR
$9.4B
| $1.15M | ﹤0.01% |
143,244
-43,683
| -23% | -$322K |
|
457
Evolent Health
EVH
$520M
| $1.15M | ﹤0.01% |
37,817
-23,698
| -39% | -$766K |
|
458
Azenta
AZTA
$1.44B
| $1.12M | ﹤0.01% |
23,912
-3,307
| -12% | -$145K |
|
459
Host Hotels & Resorts
HST
$15.3B
| $1.1M | ﹤0.01% |
65,500
-23,800
| -27% | -$399K |
|
460
Aramark
ARMK
$15.3B
| $1.1M | ﹤0.01% |
+35,338
| New | +$963K |
|
461
Atmus Filtration Technologies
ATMU
$3.89B
| $1.1M | ﹤0.01% |
+50,000
| New | +$1.05M |
|
462
Colgate-Palmolive
CL
$72.3B
| $1.07M | ﹤0.01% |
13,863
+161
| +1% | +$12.5K |
|
463
Zoetis
ZTS
$32B
| $1.04M | ﹤0.01% |
6,043
+3,936
| +187% | +$681K |
|
464
Americold
COLD
$4.29B
| $1.03M | ﹤0.01% |
31,942
-1,152,767
| -97% | -$34.3M |
|
465
Corteva
CTVA
$56B
| $992K | ﹤0.01% |
17,319
-136,447
| -89% | -$7.96M |
|
|
SWAV
466
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $988K | ﹤0.01% |
3,460
-7,591
| -69% | -$2.11M |
|
|
UNVR
467
DELISTED
Univar Solutions Inc.
UNVR
| $976K | ﹤0.01% |
27,229
-74,826
| -73% | -$2.66M |
|
468
Sarepta Therapeutics
SRPT
$2.2B
| $956K | ﹤0.01% |
+8,344
| New | +$1.08M |
|
|
FTCH
469
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $948K | ﹤0.01% |
+157,012
| New | +$756K |
|
470
Cooper Companies
COO
$13.9B
| $947K | ﹤0.01% |
9,884
-54,404
| -85% | -$5.1M |
|
471
Dick's Sporting Goods
DKS
$12.1B
| $941K | ﹤0.01% |
7,115
-11,447
| -62% | -$1.57M |
|
472
Teva Pharmaceuticals
TEVA
$42.5B
| $920K | ﹤0.01% |
122,207
-314,897
| -72% | -$2.55M |
|
473
Academy Sports + Outdoors
ASO
$2.7B
| $898K | ﹤0.01% |
+16,623
| New | +$955K |
|
474
Southwest Airlines
LUV
$19.4B
| $873K | ﹤0.01% |
24,107
+16,509
| +217% | +$518K |
|
475
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$111M
| $856K | ﹤0.01% |
30,200
-7,900
| -21% | -$213K |
|
Similar funds
Brookfield Corp's Q2 2023 Portfolio in Review
As of Q2 2023, Brookfield Corp held 801 positions worth $25.3B, down 2.8% from $26.1B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Brookfield Corp's Q2 2023 filing shows 140 new, 161 increased, 253 reduced and 224 closed positions. Its largest new stake was Vivmark Residential: 783,044 shares worth $51.7M. The largest sale was Eversource Energy, an estimated $155M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Energy and Utilities.
- Brookfield Corp's largest Q2 2023 buy was Vivmark Residential: 783,044 shares worth $51.7M.
- Brookfield Corp added most to Brookfield Business Corp Class A Subordinate Voting Shares in Q2 2023, an estimated $945M increase.
- Brookfield Corp's biggest Q2 2023 reduction was FirstEnergy, cutting an estimated $148M.
- Brookfield Corp fully exited Eversource Energy in Q2 2023, selling an estimated $155M.
- Brookfield Corp's ten largest holdings make up 67% of its $25.3B portfolio in Q2 2023.
- Brookfield Corp opened 140 new positions and closed 224 in Q2 2023.
- Brookfield Corp's portfolio value fell 2.8% quarter-over-quarter to $25.3B.
Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.